Irritable Bowel Syndrome with predominant constipation
Conditions
Interventions
Western medicine control group:macrogol 4000 powder + Otilonium bromide
TCM control group:Maren pils +Otilonium bromide
Sponsors
Chengdu Integrated TCM & Western Medicine Hospital
Eligibility
Sex/Gender
Male
Age
19 Years to 63 Years
Inclusion criteria
Inclusion criteria: (1) Meet the Rome IV diagnostic criteria for Irritable Bowel Syndrome with predominant constipation; (2) Age >=18 years and <=65 years; (3) Both men and women; (4) Voluntarily accept and comply with the trial protocol and follow-up on time; (5) Sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant and breastfeeding women, or female patients who have family planning during the study period; (2) patients with mental diseases; (3) Patients with allergies or contraindications to the drugs used in this study; (4) have used other digestive system drugs in the previous 2 weeks; (5) Patients with digestive system tumors, gastrointestinal surgery history, inflammatory bowel disease, intestinal obstruction, gastrointestinal bleeding; (6) Those had poor compliance in comprehensive judgment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| complete spontaneous bowel movement; | — |
Secondary
| Measure | Time frame |
|---|---|
| Bristol stool form scale;Irritable Bowel Syndrome symptom severity scale;numeric rating scales; | — |
Countries
China
Contacts
Public ContactZhan Yu
Chengdu Integrated TCM & Western Medicine Hospital
Outcome results
None listed